Actively Recruiting
Evaluating Stool DNA Testing for Detecting Colorectal Cancer in Lynch Syndrome Patients The CORAL Study
Led by Mayo Clinic · Updated on 2026-08-18
950
Participants Needed
9
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a DNA screening technique to detect colorectal cancer or advanced neoplasia in patients with Lynch syndrome. The study focuses on assessing the accuracy of the multitarget stool DNA mt-sDNA 2.0 test for identifying colorectal neoplasia in this high-risk group. Additionally, it aims to develop a collection of blood and stool samples from patients with Lynch syndrome and early onset colorectal cancer to support future research. Participants provide blood and stool samples either up to 90 days before or between 7 to 90 days after their scheduled colonoscopy or flexible sigmoidoscopy. Alongside sample collection, researchers review patients medical records for additional relevant information. The study involves no investigational treatments but focuses on observational biospecimen collection and health record examination. During the study, participants undergo sample collection and medical record review within the outlined timeframes. Researchers measure the sensitivity and specificity of the mt-sDNA 2.0 test in detecting colorectal neoplasia and dysplasia over a period of up to four years. The total participation duration varies depending on the timing of sample collection and follow-up, with no additional treatment or interventions required.
CONDITIONS
Brief Title
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Research Team
R
Rosalie Himle
C
Clinical Trials Referral Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here